EDAP outlines road to FDA approval for prostate cancer ultrasound therapy

French device maker EDAP TMS SA has a big month ahead as it pursues FDA approval for its Ablatherm-HIFU therapeutic ultrasound technology, preparing for regulatory inspections and launching a $9.3 million funding round.

EDAP TMS SA, Food & Drug Administration (FDA)

News Well, Regulatory/Clearance, Food & Drug Administration (FDA), Funding Roundup, Pre-Market Approval (PMA), Prostate, Ultrasound

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1wrgykz